knowledge -WSS

knowledge

author：knowledge 2025-09-27 19:28:14 - browse：4781

intarcia implant. -- health tech coverage from STAT — The matchstick-sized, implantable device from Intarcia Therapeutics releases a steady, continuous, and low-dose stream of a drug for diabetes. Stuart Isett/Fortune Brainstorm Health

An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said implant not once, but twice.

Intarcia called for the panel meeting because of those two rejections, seeking outside input on the FDA’s decision. FDA then granted Intarcia’s request. The agency is not bound to advisory panel decisions, though it tends to follow their advice.

Intarcia started developing its lead therapy, a small, skinny bar implanted under the skin, for type 2 diabetes patients in 2016. The implant delivers a glucose-controlling medicine called exenatide, a member of the GLP-1 drugs that have taken the diabetes and obesity markets by storm. Intarcia’s implant continuously administers the drug over six months, with the goal of improving patient adherence compared to Eli Lilly and Novo Nordisk’s weekly GLP-1 shots.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： WATCH: Why do fingernails fall off when they're damaged?

WSS

Kellogg’s is going to war over Mexico’s nutrition label rules

Why are elite athletes different? Take a look at their microbes

Wegovy improves function in certain heart failure patients

Abortion policy in the spotlight at Republican debate

People can get long Covid without testing positive for virus: Study

With FDA staff opposed to Sarepta therapy, top official intervened

leisure time

knowledge

Wikipedia

Medical leaders decry Supreme Court decision on affirmative action

Wegovy improves function in certain heart failure patients

State Dept. review finds Biden bears some blame for Afghanistan failures

The battle over the Brookhaven Landfill on Long Island

Moonlake's readout produced a cash windfall. Risks remain

Gene therapy has helped boys walk. Can scientists keep it that way?

ChatGPT in medicine: STAT answers readers' burning questions

Do masks work? RCTs can't tell us

Malaria cases in Florida and Texas: Here’s what you need to know

FDA greenlights medical device to combat bladder issues

knowledge

Republicans love RFK Jr. What's that tell us about health in 2024?

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Roche's accidental data boosts hopes for anti

Ask STAT: What do you want to know about ChatGPT in medicine?

California store owner shot dead in dispute over displaying Pride flag: Police

Meadows told special counsel he could not recall Trump ever declassifying Mar

entertainment

hotspot

focus

knowledge